The Impact of Sarcopenia and Myosteatosis on Postoperative Outcomes in Patients with Inflammatory Bowel Disease

Overview

Journal Eur Radiol Exp

Date 2018 Nov 22

PMID 30460523

Citations 25

Authors

Stephen OBrien

Richard G Kavanagh

Brian W Carey

Michael M Maher

Owen J OConnor

Emmet J Andrews

Affiliations

Soon will be listed here.

Abstract

Background: Inflammatory bowel disease (IBD) is a relatively common disorder with significant associated morbidity. Sarcopenia and myosteatosis are associated with adverse postoperative outcomes. This study investigated outcomes in IBD patients undergoing surgical resection relative to the presence of sarcopenia and myosteatosis.

Methods: A retrospective analysis of a prospectively maintained surgical database was conducted. All patients undergoing elective or emergency resection for IBD between 2011 and 2016, with a contemporaneous perioperative computed tomography (CT) scan, were included. Patient demographics, clinical and biochemical measurements were collected. Skeletal muscle index and attenuation were measured on perioperative CT scans using Osirix version 5.6.1. Univariate and multivariate regression analysis was used to identify risk factors for adverse postoperative outcomes.

Results: Seventy-seven patients (46 male, 31 female; mean age 42 years, range 20-80 years) were included. Thirty patients (30%) had sarcopenia and 26 (34%) had myosteatosis. Myosteatosis was significantly associated with increased hospital stay postoperatively (9 versus 13 days). Sarcopenia and myosteatosis were associated with hospital readmission within 30 days on univariate analysis. Multivariate regression analysis demonstrated an independent association between myosteatosis and hospital readmission. Sixteen patients (21%) had a clinically relevant postoperative complication, but an association with sarcopenia and myosteatosis was not observed. A neutrophil-lymphocyte ratio greater than 5 was predictive of clinically relevant postoperative complications on multivariate regression analysis.

Conclusions: Myosteatosis was associated with increased hospital stay and increased 30-day hospital readmission rates on multivariate regression analysis. Sarcopenia and myosteatosis in IBD were not associated with clinically relevant postoperative complications.

Citing Articles

Identification and immune landscape of sarcopenia-related molecular clusters in inflammatory bowel disease by machine learning and integrated bioinformatics.

Yue C, Xue H Sci Rep. 2024; 14(1):17603.

PMID: 39079987 PMC: 11289443. DOI: 10.1038/s41598-024-68198-w.

Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence.

Neelam P, Sharma A, Sharma V JGH Open. 2024; 8(1):e13033.

PMID: 38283070 PMC: 10821747. DOI: 10.1002/jgh3.13033.

Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.

Donnelly M, Driever D, Ryan E, Elliott J, Finnegan J, McNamara D Inflamm Bowel Dis. 2023; 30(9):1517-1528.

PMID: 37861366 PMC: 11369076. DOI: 10.1093/ibd/izad225.

Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicentre study.

Zhang Y, Zhang L, Gao X, Dai C, Huang Y, Wu Y J Cachexia Sarcopenia Muscle. 2023; 14(6):2663-2675.

PMID: 37779327 PMC: 10751433. DOI: 10.1002/jcsm.13341.

Computed tomography derived cervical fat-free muscle fraction as an imaging-based outcome marker in patients with acute ischemic stroke: a pilot study.

Mesropyan N, Khorsandian L, Faron A, Sprinkart A, Dorn F, Paech D BMC Neurol. 2023; 23(1):86.

PMID: 36855093 PMC: 9971678. DOI: 10.1186/s12883-023-03132-7.

References

Montano-Loza A, Angulo P, Meza-Junco J, Prado C, Sawyer M, Beaumont C . Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle. 2016; 7(2):126-35. PMC: 4864157. DOI: 10.1002/jcsm.12039. View

Rocha R, Santana G, Almeida N, Lyra A . Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase. Br J Nutr. 2008; 101(5):676-9. DOI: 10.1017/S0007114508032224. View

Connelly T, Juza R, Sangster W, Sehgal R, Tappouni R, Messaris E . Volumetric fat ratio and not body mass index is predictive of ileocolectomy outcomes in Crohn's disease patients. Dig Surg. 2014; 31(3):219-24. DOI: 10.1159/000365359. View

Scaldaferri F, Pizzoferrato M, Lopetuso L, Musca T, Ingravalle F, Sicignano L . Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide. Gastroenterol Res Pract. 2017; 2017:8646495. PMC: 5239980. DOI: 10.1155/2017/8646495. View

Zhang T, Ding C, Xie T, Yang J, Dai X, Lv T . Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy. Clin Nutr. 2016; 36(6):1586-1592. DOI: 10.1016/j.clnu.2016.10.004. View

Holt D, Strauss B, Moore G . Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2016; 7(10):e199. PMC: 5288590. DOI: 10.1038/ctg.2016.56. View

Bahat G, Tufan A, Tufan F, Kilic C, Akpinar T, Kose M . Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016; 35(6):1557-1563. DOI: 10.1016/j.clnu.2016.02.002. View

Cosnes J, Gower-Rousseau C, Seksik P, Cortot A . Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011; 140(6):1785-94. DOI: 10.1053/j.gastro.2011.01.055. View

Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin M, McCargar L . Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013; 31(12):1539-47. DOI: 10.1200/JCO.2012.45.2722. View

10.

Mitsiopoulos N, Baumgartner R, Heymsfield S, Lyons W, Gallagher D, Ross R . Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985). 1998; 85(1):115-22. DOI: 10.1152/jappl.1998.85.1.115. View

11.

Kilcoyne A, Kaplan J, Gee M . Inflammatory bowel disease imaging: Current practice and future directions. World J Gastroenterol. 2016; 22(3):917-32. PMC: 4716045. DOI: 10.3748/wjg.v22.i3.917. View

12.

Mik M, Dziki L, Berut M, Trzcinski R, Dziki A . Neutrophil to Lymphocyte Ratio and C-Reactive Protein as Two Predictive Tools of Anastomotic Leak in Colorectal Cancer Open Surgery. Dig Surg. 2017; 35(1):77-84. DOI: 10.1159/000456081. View

13.

Nguyen G, Munsell M, Harris M . Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis. 2008; 14(8):1105-11. DOI: 10.1002/ibd.20429. View

14.

Appau K, Fazio V, Shen B, Church J, Lashner B, Remzi F . Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg. 2008; 12(10):1738-44. DOI: 10.1007/s11605-008-0646-0. View

15.

Stidham R, Waljee A, Day N, Bergmans C, Zahn K, Higgins P . Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn's disease. Inflamm Bowel Dis. 2015; 21(6):1306-13. PMC: 4437863. DOI: 10.1097/MIB.0000000000000360. View

16.

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

17.

Kasparek M, Bruckmeier A, Beigel F, Muller M, Brand S, Mansmann U . Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery. Inflamm Bowel Dis. 2011; 18(7):1207-13. DOI: 10.1002/ibd.21860. View

18.

Huang D, Wang S, Zhuang C, Zheng B, Lu J, Chen F . Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis. 2015; 17(11):O256-64. DOI: 10.1111/codi.13067. View

19.

da Silva B, Lyra A, Rocha R, Santana G . Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol. 2014; 20(28):9458-67. PMC: 4110577. DOI: 10.3748/wjg.v20.i28.9458. View

20.

Reisinger K, van Vugt J, Tegels J, Snijders C, Hulsewe K, Hoofwijk A . Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2014; 261(2):345-52. DOI: 10.1097/SLA.0000000000000628. View